<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01638624</url>
  </required_header>
  <id_info>
    <org_study_id>Diskapi2012</org_study_id>
    <nct_id>NCT01638624</nct_id>
  </id_info>
  <brief_title>The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury</brief_title>
  <official_title>The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <brief_summary>
    <textblock>
      The release of tourniquet produces reactive oxygen species which can cause injury. Propofol
      is chemically similar to phenol-based free radical scavengers.

      Plasma total antioxidant capacity is a well-established marker of the overall protective
      effect of antioxidants in body fluids.The aim of the study is to investigate the effects of
      propofol on ischemia-reperfusion injury in total knee arthroplasty (TKA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The perioperative alternation of the venous blood total antioxidant capacity levels of the arms</measure>
    <time_frame>T1,T2,T3</time_frame>
    <description>T1 : Before the spinal anesthesia performed T2 : At 30th min of tourniquet inflation T3 : At 2nd hours of tourniquet deflation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Tourniquet-Induced Ischemia-Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol infusion group: Under spinal anesthesia, a continuous intravenous infusion (2mg/kg/h) of propofol will be use during the operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo group: Under spinal anesthesia, a continuous intravenous infusion of volume-equivalent placebo will use during the operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol :Propofol is an anesthetic agent, has structure similar to that of known such as alfa tocopherol.</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II physical status

          -  Unilateral total knee arthroplasty

          -  Age 18 years to 80 years

        Exclusion Criteria:

          -  Severe central nervous system disorders

          -  Severe cardiopulmonary,renal,metabolic, or hepatic disease,

          -  Blood volume deficits,

          -  Coagulopathy,

          -  Allergy to local anesthetics,

          -  Peripheral neuropathies,

          -  Body mass index &gt; 35,

          -  History of antioxidant drug use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derya Özkan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Taylan Akkaya, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Yalcindag, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Biochemistry Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tuba Hanci, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Biochemistry Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haluk Gümüs, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Namik Delibas, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Biochemistry Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emel Gönen, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Orthopedics Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital Anesthesiology and Biochemistry Clinics</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2012</study_first_submitted>
  <study_first_submitted_qc>July 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2012</study_first_posted>
  <last_update_submitted>June 10, 2016</last_update_submitted>
  <last_update_submitted_qc>June 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>derya özkan</investigator_full_name>
    <investigator_title>Consultant MD of Anesthesiology Department</investigator_title>
  </responsible_party>
  <keyword>Propofol</keyword>
  <keyword>antioxidant capacity</keyword>
  <keyword>total knee arthroplasty</keyword>
  <keyword>Propofol,antioxidant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

